Cargando…
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm
IMPORTANCE: High-dose omega-3 docosahexaenoic acid (DHA) supplementation of children born at less than 29 weeks’ gestation has been shown to improve IQ despite increasing the risk of bronchopulmonary dysplasia (BPD). Given that BPD is associated with poorer cognitive outcomes, it is unclear whether...
Autores principales: | Sullivan, Thomas R., Gould, Jacqueline F., Bednarz, Jana M., McPhee, Andrew J., Gibson, Robert, Anderson, Peter J., Best, Karen P., Sharp, Mary, Cheong, Jeanie L.Y., Opie, Gillian F., Travadi, Javeed, Davis, Peter G., Simmer, Karen, Collins, Carmel T., Doyle, Lex W., Makrides, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257101/ https://www.ncbi.nlm.nih.gov/pubmed/37294565 http://dx.doi.org/10.1001/jamanetworkopen.2023.17870 |
Ejemplares similares
-
Protocol for assessing whether cognition of preterm infants <29 weeks’ gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021) -
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
por: Collins, Carmel T., et al.
Publicado: (2016) -
Protocol for assessing if behavioural functioning of infants born <29 weeks’ gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021) -
Neurodevelopmental outcomes at 7 years’ corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial
por: Collins, Carmel T, et al.
Publicado: (2015) -
Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis
por: Marc, Isabelle, et al.
Publicado: (2023)